Friday, 17th September 12pm (AEST)
This exclusive event gives investors unprecedented access to Australia’s leading fund managers to hear about their favourite companies, unique market insights, and the opportunity to ask questions.
This is an opportunity to hear from Matt McNamara, CIO & Board Director at Horizon 3 Biotech.
Join Matt to learn about:
- 3 favourite biotech stocks
- Horizon 3’s unique approach addresses the common pitfalls of biotech
- Why this booming sector creates opportunities for his fund to target an IRR of 20%+
This is a live and interactive online session, and participants are encouraged to ask questions. Joining only requires an internet connection. Spots are limited, so secure yours today .
Horizon 3 Biotech
Matt is a specialist in human healthcare technology and is passionate about investing in the commercialisation of this industry. He has spent more than 30 years in the healthcare and medical sciences sector and has more than 20 years’ experience as a venture capitalist. Matt has served as the CIO at BioScience Managers ($200m FUM, >20% IRR), CEO of SciCapital pre-seed fund, SVP Business Development for eBioinformatics Inc and has an exciting portfolio of executive/non-executive board and advisory roles. His business acumen and strong background in the life sciences sector make him one of the industry’s most credible investment voices.